Phosphorylation of BRCA1, γH2AX, Chk1 and Chk2 observed in cryptolepine treated cells is also supported by the evidences that have demonstrated that clinically used cancer chemotherapeutic agents which inhibit topoisomerase functions also activate these signaling cascade [20,23]. The gene discussed is CHEK2; the disease is cancer.